SG Americas Securities’s Centessa Pharmaceuticals CNTA Stock Holding History

SG Americas Securities’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,081	Closed	-$122K	–	3400
2026 Q1	$122K	Sell	3,081 -260,544	-99%	-$6.66M	﹤0.01%	2859
2025 Q4	$6.59M	Buy	263,625 +240,039	+1,018%	+$6.08M	0.01%	968
2025 Q3	$572K	Buy	+23,586	New	+$419K	﹤0.01%	2003

SG Americas Securities's CNTA Position: Q2 2026 in Review

SG Americas Securities sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 3,081 shares — an estimated $122K sold.

SG Americas Securities first reported a position in CNTA in Q3 2025 and held it in 3 quarters. The position peaked at $6.59M in Q4 2025. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

SG Americas Securities reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
SG Americas Securities sold 3,081 Centessa Pharmaceuticals shares in Q2 2026, an estimated $122K.
SG Americas Securities first reported a position in Centessa Pharmaceuticals in Q3 2025 and held it in 3 quarters.
SG Americas Securities's Centessa Pharmaceuticals position peaked at $6.59M in Q4 2025.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.